IP Verse

Argenx competitive analysis

Loading summary...

Latest patents of Argenx opposed by its competitors

Explore Argenx's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3728328
Oct 23, 2024Bispecific Antigen Binding Construct2
EP3638696
Jun 26, 2024Use Of Anti Cd70 Antibody Argx-110 To Treat Acute Myeloid Leukaemia1
EP3087095
Aug 7, 2019Fcrn Antagonists And Methods Of Use1

Latest publications and patents of Argenx New

Explore the latest publications and patents granted to Argenx, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Argenx

EP3728328
Oct 23, 2024Bispecific Antigen Binding ConstructGranted And Under Opposition
EP3638696
Jun 26, 2024Use Of Anti Cd70 Antibody Argx-110 To Treat Acute Myeloid LeukaemiaGranted And Under Opposition
EP3087095
Aug 7, 2019Fcrn Antagonists And Methods Of UseGranted And Under Opposition

Latest PTAB cases involving Argenx

Discover the latest PTAB cases involving Argenx, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Argenx with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ARGENX BVBA - 4 - -
PFIZER51874312
SANOFI5923 - -
SIMMONS & SIMMONS7 - - -